News

BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drug development.

Beijing-headquartered clinical genomics testing company, Berry Genomics and Hong Kong and London-headquartered genetics and digital health company Prenetics announced today key management hires for the new company, Circle DNA, which will be operational for business by the end of Q2 2019.

Equity Group Investments led the Series A round, the first funding round for the company.

The Tandem Diabetes Care t:Slim X2 can work in tandem with other blood sugar management devices, or on its own.

The round was led by Gates Frontier with participation from Khosla Ventures, Innovation Endeavors, AME Cloud Ventures and Marc Benioff. 

The Verisense platform is designed to address problems created by consumer devices in the clinical research world.

The report also showed a decline in consumers' willingness to share data with healthcare stakeholders. 

Emedgene's constantly updating algorithm highlights genetic variants that could affect a patient's health. 

This morning Glooko also announced that its diasend platform will be compatible with the Dexcom G6. 

Also: Health at Hand signs on with Allianz Care; Sutter Health taps Ada Health for personalized guidance.